镰状红细胞病合并脑卒中的研究进展  

Recent advance in sickle cell disease combined with stroke

作　　者：侯清华[1] 周列民 Hou Qinghua;Zhou Lie min(Clinical Neuroscience Center,Seventh Affiliated Hospital,Sun Yat-Sen University,Shenzhen 518017,China)

机构地区：[1]中山大学附属第七医院神经医学中心,深圳518107

出　　处：《中华神经医学杂志》2020年第7期735-740,共6页Chinese Journal of Neuromedicine

摘　　要：镰状红细胞病(SCD)是一种输入性病种,该病患者发生心脑血管事件的概率较正常人群显著提高。SCD患者发生的脑卒中和动脉粥样硬化引起的脑卒中有较大的不同,治疗和二级预防方法也有其特殊性。本文现围绕其发病机制、治疗及预防3方面做一简要介绍,以增加临床工作人员对SCD合并脑卒中的认识。Sickle cell disease(SCD)is an imported disease,and patients with SCD have obviously higher incidence of cardiovascular and cerebrovascular diseases.Stroke in SCD patients is quite different from those caused by atherosclerosis,and treatments and secondary prevention methods are also unique.This article reviews the pathogenesis,treatment and prevention of stroke in SCD patients briefly,aiming to increase the domestic understanding of SCD combined with stroke.

关 键 词：镰状红细胞病 脑卒中 病理生理 

分 类 号：R743.3[医药卫生—神经病学与精神病学] R555[医药卫生—临床医学]